Table 3. Impact on effectiveness of 15 mg or 30 mg phentermine from 3 to 6 months.
Previous weight reduction phentermine 15 mg 0 – 3 months |
Final weight reduction 3 – 6 months | |||
< 5% | ≥ 5% – <10% | ≥ 10% | Total effectiveness ≥ 5% |
|
< 5% (n = 43) | 22 (51.2%) | 20 (46.5%) | 1 (2.3%) | 21 (48.8%) |
≥ 5 – <10% (n = 52) | 7 (13.5%) | 22 (42.3%) | 23 (44.2%) | 45 (86.5%) |
≥ 10% (n = 31) | – | – | 31 (100%) | 31 (100%) |
Previous weight reduction phentermine 30 mg 0 – 3 months | Final weight reduction 3 – 6 months | |||
< 5% | ≥ 5% – <10% | ≥ 10% | Total effectiveness ≥ 5% |
|
< 5% (n = 45) | 28 (62.3%) | 17 (37.7%) | – | 17 (37.7%) |
≥ 5 – < 10% (n = 83) | 5 (6.1%) | 47 (56.6%) | 31 (37.3%) | 78 (93.9%) |
≥ 10% (n = 57) | – | 12 (20.6%) | 45 (79.4%) | 57 (100%) |
Data expressed as the number of patients (%).